Science Daily: Pharmacology News
FEBRUARY 25, 2024
A drug that binds to allergy-causing antibodies can protect children from dangerous reactions to accidentally eating allergy-triggering foods, a new study found.
SCIENMAG: Medicine & Health
FEBRUARY 25, 2024
ANN ARBOR, Mich. – While it’s not surprising to spot teens wearing headphones and earbuds, it’s also becoming a widespread trend among younger children, a national poll suggests. Credit: University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health ANN ARBOR, Mich.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
FEBRUARY 25, 2024
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. It is available from one supplier.… The post New patent expiration for Endo Pharms drug NASCOBAL appeared first on DrugPatentWatch - Make Better Decisions.
Covalent Modifiers
FEBRUARY 25, 2024
Gan-Qiang Lai, Yali Li, Heping Zhu, Tao Zhang, Jing Gao, Hu Zhou and Cai-Guang Yang RSC Chem. Biol. , 2024 , DOI: 10.1039/D3CB00230F N6-Methyladenosine (m6A) is the most prevalent mRNA modification and is required for gene regulation in eukaryotes. ALKBH5, an m6A demethylase, is a promising target, particularly for anticancer drug discovery. However, the development of selective and potent inhibitors of ALKBH5 rather than FTO remains challenging.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drug Patent Watch
FEBRUARY 25, 2024
Annual Drug Patent Expirations for GRALISE Gralise is a drug marketed by Almatica and is included in one NDA. It is available from one supplier. There is one patent protecting… The post New patent expiration for Almatica drug GRALISE appeared first on DrugPatentWatch - Make Better Decisions.
ProRelix Research
FEBRUARY 25, 2024
The role of Real-World Evidence (RWE) in drug development helps in gaining a deep insight into how real-world data and experiences come together to shape impactful pharmaceutical solutions. Introduction to […] The post The Role of Real-World Evidence (RWE) in Drug Development: ProRelix Research Insights appeared first on ProRelix Research.
Drug Patent Watch
FEBRUARY 25, 2024
This chart shows the pharmaceutical companies with the most patents in Serbia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Serbia? appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
126 
Let's personalize your content